The global C-reactive protein testing market expected to Reach US$ 1.99 Billion by 2027 according to a new study by Polaris Market Research. The report “C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay), By Detection Range (hs-CRP, Conventional CRP, cCRP), By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus), By End-Use; By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/c-reactive-protein-testing-market/request-for-sample
The key factors responsible for the market growth are recent surge in COVID-19 cases across the globe, market players’ focused approach towards PoC diagnosis, new innovations, and clinical trials in the biomarker discovery. Moreover, the emerging countries, owing to their huge population base, particularly India and China, focusing on rapid tests, which is cost effective and reliable.
The market is fragmented based on assay type, detection range, disease area, end-use, and region. In terms of product, the market is segmented into immuno-turbidimetric assay, ELISA, chemiluminescence immunoassay, and others. Based on detection range, the market is further bifurcated into hs-CRP, conventional CRP, and cCRP. Based on disease area, the market is classified as cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus, and others. The end-use segment is further divided into clinics, hospitals, laboratories, assisted living healthcare facilities, home, and others
Segment Highlights
- The immuno-turbidimetric segment accounted for the largest revenue share of the market owing to its high specificity and accuracy rate. However, the chemiluminescence assay segment is expected to witness fastest growth over the forecast.
- Based on detection range, the hs-CRP test segment is projected to constitute almost half of the market in 2027. The segment holds majority of share due to its aggressive use in the healthcare industry to check pandemic infections across the regions.
- Cardiovascular diseases accounted for the largest revenue share in 2019 on account of the increasing use of C-reactive protein testing CVD across the regions. In addition, the growing incidences of fatal diseases is expected to drive the market growth.
- North America is accounted for the largest revenue share in 2019 owing to excellent reimbursement setup. However, Asia Pacific is expected to witness fastest revenue growth over the coming years.
Complete Summary with TOC Available@ https://www.polarismarketresearch.com/industry-analysis/c-reactive-protein-testing-market/toc
List of Key Players
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Roche Ltd.
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Abbott Laboratories
- Others
Polaris Market Research has segmented the C-Reactive Protein Testing Market report on the basis of Assay Type, Detection Range, Disease Area, Type and Region
C-reactive Protein Testing, Assay Type Outlook (Revenue – USD Million, 2016 – 2027)
- Immuno-turbidimetric Assay
- ELISA
- Clinical
- Nonclinical
- Chemiluminescence Immunoassay
- Others
C-reactive Protein Testing, Detection Range Outlook (Revenue – USD Million, 2016 – 2027)
- hs-CRP
- Conventional CRP
- cCRP
C-reactive Protein Testing, Disease Area Outlook (Revenue – USD Million, 2016 – 2027)
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
C-reactive Protein Testing, End-Use Outlook (Revenue – USD Million, 2016 – 2027)
- Clinics
- Hospitals
- Laboratories
- Assisted Living Healthcare Facilities
- Home
- Others
C-reactive Protein Testing, Regional Outlook (Revenue – USD Million, 2016 – 2027)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Spain
- Netherlands
- Austria
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Central & South America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Avail discount on this report @ https://www.polarismarketresearch.com/industry-analysis/c-reactive-protein-testing-market/request-for-discount-pricing
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.
Contact us-
Polaris Market Research
Phone: 1-646-568-9980
Email: [email protected]
The global C-reactive protein testing market expected to Reach US$ 1.99 Billion by 2027 according to a new study by Polaris Market Research.
The report “C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay), By Detection Range (hs-CRP, Conventional CRP, cCRP), By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus), By End-Use; By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Moreover, the emerging countries, owing to their huge population base, particularly India and China, focusing on rapid tests, which is cost effective and reliable.
Based on disease area, the market is classified as cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus, and others.
The end-use segment is further divided into clinics, hospitals, laboratories, assisted living healthcare facilities, home, and others Segment HighlightsThe immuno-turbidimetric segment accounted for the largest revenue share of the market owing to its high specificity and accuracy rate.
The segment holds majority of share due to its aggressive use in the healthcare industry to check pandemic infections across the regions.Cardiovascular diseases accounted for the largest revenue share in 2019 on account of the increasing use of C-reactive protein testing CVD across the regions.
The Factors driving the growth of Biobanking Devices Market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research; and the growing need for cost-effective drug discovery and development.According to the new market research report “Biobanking Market by Product and Service(Equipment, Consumables, Services, Software), Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids), Application( Regenerative Medicine, Life Science, Clinical Research) – Global Forecast” published by MarketsandMarkets™, is expected to reach $2.69 billion, at a CAGR of 7.8%Regenerative medicine applications for biobanking market will drive the growth;Biobanking Devices Market plays an integral role in advancing biomedical and translational research, through the collection and preservation of biological samples, such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this is further used for diagnosis, prognosis, and predicting drug responses.
Growth in the number of research activities in this segment forms a major driver for the market.
The availability of government funding for regenerative medicine, stem cell therapeutics, and cell & gene therapy is supporting research activities in this segment.
Apart from this, the increasing trend of cord blood banking will also aid growth of this market segment.
Future prospects including advancements in orthopedic procedures with the use of stem cells are expected to further support market growth for regenerative medicine.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=594Geographically; segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
North America is expected to dominate the biobanking market in 2017, this is attributed to factors like increasing research activities in regenerative medicine, cell and gene therapy; growing interest in personalized medicine and biomarker discovery; increasing number of biotechnology and pharmaceutical companies; and rising investments in genomics and proteomics research in the region as compared to other regions.Key players in the biobanking market include Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)], Chart Industries (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Micronic (Netherlands).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594Market Segmentation in Detailed:The equipment segment is expected to dominate the biobanking Devices MarketBy product and service, segmented into equipment, consumables, services, and software.
The Glucaric Acid Market is anticipated to reach over USD 1,467 million by 2026 according to a new research published by Polaris Market Research.
In 2017, the detergents segment dominated the global market, in terms of revenue.
Glucaric acid is increasingly replacing phosphates in detergents owing to stringent regulations regarding harmful environmental effects of phosphates, thereby supporting market growth.
Increasing demand from developing nations, and growing use in healthcare sector is expected provide numerous growth opportunities to the market players during the forecast period.
Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/glucaric-acid-market/request-for-sample Asia-Pacific Glucaric acid Market generated the highest revenue in 2017, and is expected to lead the global market throughout the forecast period.
The rising use in agriculture and chemical industries in the region drive the market growth.
Increasing government funding for cell-based research and the rising incidence of chronic and infectious diseases are the major factors driving the growth of this market.The Cell Analysis Market is expected to reach USD 22.7 billion by 2024 from USD 16.0 billion in 2019, at a CAGR of 7.2%.
from 2019 to 2024Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946Market Segmentation:-Based on product, the cell analysis market is broadly categorized into microscopes, flow cytometry products, spectrophotometers, qPCR products, cell counters, cell microarrays, high-content screening (HCS) systems, and other products.
The flow cytometry products segment accounted for the largest market share in 2018.
The large share of this segment is primarily attributed to technological advancements, the increasing adoption of flow cytometry techniques in research and academia, growing public-private initiatives in the field of immunology and immuno-oncology research, and the rising incidence and prevalence of chronic diseases.Based on end user, the cell analysis market is segmented into hospitals & diagnostic laboratories, research institutes, pharmaceutical & biotechnology companies and CROs, cell culture collection repositories, and other end users.
The pharmaceutical & biotechnology companies and CROs segment is expected to register the highest CAGR during the forecast period.
These facilities use cell analysis instruments and consumables during various stages of drug discovery, drug research and development, pharmacokinetics, toxicology, and clinical studies.
April 15, 2019: This report focuses on the global Clinical Laboratory Test status, future forecast, growth opportunity, key market and key players.
The study objectives are to present the Clinical Laboratory Test development in United States, Europe and China.The growing geriatric population base, primarily in the European and North American countries, is also anticipated to provide huge growth opportunities in this area.
The increase in aging population and amplified acute and long-term healthcare needs are driving the growth of clinical laboratory tests market at a global level.
Moreover, rising awareness amongst people and healthcare professionals about the need of regular body profiling is also estimated to enhance usage of clinical tests.Download sample Copy of This Report at: https://www.radiantinsights.com/research/global-clinical-laboratory-test-market-size-status-and-forecast-2018-2025/request-sample Increasing adoption of laboratory automation systems is anticipated to accentuate growth of this market over the next decade.
For example, approximately more than 30% of the laboratories in North America, Europe, and Japan have implemented a significant degree of laboratory automation.Advantages of automation such as its ability to reduce errors, improve efficacy, and enhance patient safety by integrating electronic, mechanical, and informatics tools are expected to propel the market.In 2017, the global Clinical Laboratory Test market size was 208800 million US$ and it is expected to reach 344500 million US$ by the end of 2025, with a CAGR of 6.5% during 2018-2025.Browse Full Report With TOC @ https://www.radiantinsights.com/research/global-clinical-laboratory-test-market-size-status-and-forecast-2018-2025The key players covered in this studyQuest DiagnosticsMerck KgaALaboratory Corporation of America HoldingsGenoptixHealthscopeLabcoCharles River LaboratoriesOPKO Health, IncAbbottMarket segment by Type, the product can be split intoComplete Blood CountHGB/HCT TestingBasic Metabolic Panel TestingBUN Creatinine TestingElectrolytes TestingHbA1c TestingComprehensive Metabolic Panel TestingLiver PanelTestingRenal Panel TestingLipid Panel TestingMarket segment by Application, split intoClinical Laboratory test CentersHospitals/ clinicsAcademic research institutesGovernment institutesMarket segment by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South AmericaThe study objectives of this report are:To analyze global Clinical Laboratory Test status, future forecast, growth opportunity, key market and key players.To present the Clinical Laboratory Test development in United States, Europe and China.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by product type, market and key regions.In this study, the years considered to estimate the market size of Clinical Laboratory Test are as follows:History Year: 2013-2017Base Year: 2017Estimated Year: 2018Forecast Year 2018 to 2025About Radiant InsightsRadiant Insights is a platform for companies looking to meet their market research and business intelligence requirements.
We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process.
The In-Vitro Toxicology Testing Market Research Report Forecast is a valuable source of insightful data for business strategists.
It provides the industry overview with recent trends, size, share, growth analysis, historical, futuristic data, revenue, demand and strategic development.The report segments the anthracite market and analyses it with respect to the geography, intending to keep the marketer informed and help them identify the target demographics for the product or service.Request a FREE Sample Copy of Global In-Vitro Toxicology Testing Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/in-vitro-toxicology-testing-market/download-sampleBy TechnologyCell Culture TechnologyHigh Throughput TechnologyMolecular ImagingOMICS TechnologyBy MethodCellular AssayBiochemical AssayIn SilicoEx-vivoBy ApplicationSystemic ToxicologyDermal ToxicityEndocrine DisruptionOcular ToxicityOthersBy End-UsePharmaceutical IndustryCosmetics & Household ProductsDiagnosticsChemicals IndustryFood IndustryBrowse Full Global In-Vitro Toxicology Testing Market Research Report With TOC At: https://www.valuemarketresearch.com/report/in-vitro-toxicology-testing-marketThe research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the In-Vitro Toxicology Testing market include Agilent Technologies, Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Charles River, Thermo Fisher Scientific Inc., Catalent, Inc., Eurofins Scientific, GE Healthcare, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentronix, HD Biosciences Co., Ltd.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.This section covers regional segmentation which accentuates on current and future demand for In-Vitro Toxicology Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Further, the report focuses on demand for individual application segment across all the prominent regions.Purchase complete Global In-Vitro Toxicology Testing Market Research Report At: https://www.valuemarketresearch.com/contact/in-vitro-toxicology-testing-market/buy-nowAbout Us:Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.Contact:Value Market Research401/402, TFM, Nagras Road, Aundh, Pune-7.Maharashtra, INDIA.Tel: +1-888-294-1147Email: [email protected]: https://www.valuemarketresearch.com
